|
|
42
|
2372X
|
XYLOMETAZOLINE 0.1% NASAL SP (FSB)
|
10ML
|
A
|
2.42
|
0.1%
|
1
|
2026-04-01
|
|
No
|
No
|
Add to Contract as Cat A
|
0
|
|
|
40
|
23739
|
OTRIVINE 0.05% NASAL DR (GSK/COL) XYLOMETAZOL
|
10ML
|
A
|
4.70
|
0.05%
|
1
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
23739
|
OTRIVINE 0.05% NASAL DR (GSK) XYLOMETAZO (C)
|
10ML
|
C
|
4.9473
|
0.05%
|
1
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
|
42
|
23739
|
OTRIVINE 0.05% NASAL DR (GSK) XYLOMETAZO
|
10ML
|
A
|
5.19
|
0.05%
|
1
|
2026-04-01
|
|
No
|
No
|
|
0
|
|
|
41
|
2373E
|
XYLOMETAZOLINE 0.05% NASAL DR (KWA)
|
15ML
|
A
|
2.6096
|
0.05%
|
1
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
|
40
|
2373G
|
OXOZOLIN PAED 0.025% NASAL DR (ARP/AHI) OXYME
|
10ML
|
A
|
4.05
|
0.025%
|
1
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
40
|
2373S
|
XYLOMETAZOLINE 0.05% NASAL DR (CIR/AHI)
|
10ML
|
A
|
2.31
|
0.05%
|
1
|
2022-04-01
|
2022-09-30
|
|
|
|
6
|
|
|
40
|
2392B
|
PMS-RISEDRONATE 35MG TAB (PMS/COL)
|
4'S
|
C
|
3.74
|
35MG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
42
|
2392B
|
PMS-RISEDRONATE 35MG TAB (PMS)
|
4'S
|
C
|
2.38
|
35MG
|
0
|
2026-04-01
|
|
No
|
No
|
|
0
|
|
|
41
|
2392C
|
APO-RISEDRONATE 35MG TAB (APO) (C)
|
4'S
|
C
|
2.4261
|
35MG
|
0
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
|
40
|
2401A
|
IDEW-FLO 1MG STRP (ENT/PHA) FLUORESCEIN
|
100'S
|
B
|
20.12
|
1MG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
2401A
|
IDEW-FLO 1MG STRP (ENT) FLUORESCEIN
|
100'S
|
B
|
0.227
|
1MG
|
0
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
|
42
|
2401AA
|
I-DEW FLO 1MG STRP (ENT) FLUORESCEIN
|
100'S
|
B
|
0.20
|
1MG
|
0
|
2026-04-01
|
|
No
|
No
|
|
0
|
|
|
40
|
24041
|
FLUORESCEIN MINIMS 1% EYE/EAR DR (CAM/STO)
|
20X0.5ML
|
B
|
4.74
|
1%
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
24042
|
FLUORESCEIN MINIMS 1% EYE DR (CAM) (B)
|
20X0.5ML
|
B
|
4.1264
|
1%
|
0
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
|
40
|
2411B
|
HYPROMELLOSE 0.3% EYE DR (ASL/PHA)
|
10ML
|
A
|
3.75
|
0.3%
|
1
|
2022-04-01
|
2024-03-31
|
|
|
|
6
|
|
|
41
|
2411B
|
HYPROMELLOSE 0.3% EYE DR (ASL)
|
10ML
|
A
|
7.6385
|
0.3%
|
1
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
42
|
2411J
|
LACRYL SOOTHE 0.3% EYE DR (ABL) HYPROMELLOSE
|
10ML
|
A
|
3.94
|
0.3%
|
1
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
40
|
2451AF
|
LOPERAMIDE 2MG CAP (CIP/AHI)
|
30X10
|
A
|
0.09
|
2MG
|
30
|
2022-04-01
|
2024-03-31
|
|
|
|
6
|
|
|
40
|
2451AN
|
ALKA AD 2MG TAB (BSP/COL) LOPERAMIDE
|
60'S
|
C
|
0.29
|
2MG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|